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Abstract
Background: Sesquiterpene lactones (STLs) make a diverse and huge group of bio-active constituents that have
been isolated from several plant families. However, the greatest numbers are present in Asteraceae family having
more than 3000 different reported structures. Recently several researchers have reported that STLs have significant
antioxidant and anticancer potentials.
Methods: To investigate the antioxidant, anticancer and antinociceptive potentials of STLs, gravity column
chromatography technique was used for isolation from the biologically rich chloroform fraction of Artemisia
macrocephala Jacquem. The antioxidant activity of the isolated STLs was determined by DPPH and ABTS free
radical scavenging activity, anticancer activity was determined on 3 T3, HeLa and MCF-7 cells by MTT assay
while the antinociceptive activity was determined through acetic acid induced writhings, tail immersion
method and formalin induced nociception method.
Results: The results showed that the STLs of Artemisia macrocephala possesses promising antioxidant activity
and also it decreased the viability of 3 T3, HeLa and MCF-7 cells and mild to moderate antinociceptive activity.
Conclusion: Sesquiterpenes lactones (STLs) are widely present in numerous genera of the family Asteraceae
(compositae). They are described as the active constituents used in traditional medicine for the treatment of
various diseases. The present study reveals the significant potentials of STL and may be used as an alternative
for the management of cancer. Anyhow, the isolated compound is having no prominent antinociceptive potentials.
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Background
Sesquiterpenoids are extensively dispersed in plant
kingdom. They are natural products with 15 carbons
[1–3]. Numerous of them show cyclic chemical structures
[4–10]. These compounds are synthesized by plants in
several organs such as leaves, fruits or roots [11–14].
Sesquiterpene lactones (STLs) are a sub-class of sesqui-
terpenoids and are typical secondary compounds of the
Asteraceae plant family [15, 16]. In the last several
years, the potent bioactivities of STLs, such as anti-
malarial activity of artemisinin [17], drew significant
interests in the biochemistry of STLs [18]. They show
anti-microbial activities, serve as antifeedants [19–21],
as an antimigraine [22, 23], anti-inflammatory, for treat-
ment of stomach-ache, skin infection [24], antitumor, anti-
ulcer, neuro-cytotoxic, cardiotonic activities [25] and
antineoplastic activity and hence make lead structures for
the development of therapeutic agents. According to
scientific evidence, the lactone fraction obtained from
Artemisia annua L have greater potential for pain relief
revealed by chemical-induced nociception assays in mice
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[26]. Similarly several experiments have shown the antinoci-
ceptive potential of terpenes in different painful conditions.
They were able to reduce significantly the nociceptive re-
sponse in various models of nociception with possible
involvement of muscarinic, opioid, dopaminergic, adenosi-
nergic and glutamatergic systems and the involvement of
ATP-sensitive K+ channels [27]. Citronellal, a monoterpene
possess antinociceptive potentials with the involvement
of opioid system [28, 29], similarly carvacrol, p-cymene,
hydroxydihydrocarvone (monoterpene) possess antinoci-
ceptive potentials in several models of animals [30–32].
Through structural analysis and the mechanism pro-
posed by scientific studies, the monoterpenes like myr-
cene, linalool, citronellol and citronellal usually have
antinociceptive potentials via acting on the opioid sys-
tem [33].
In view of these, we studied the Hirshfeld analysis and
fingerprint plots of the crystal of STL isolated from
Artemisia macrocephala Jacquem and subjected to anti-
oxidant and cytotoxic study.
Methods
Collection and authentitacation of plant materials
Aerial parts of Artemisia macrocephala (A. macrocephala)
were collected from Badwan chowk, Dir Lower, Khyber
Pakhtunkhwa, Pakistan in the month of April, 2015. The
plant was identified by Professor Jahandar Shah. A voucher
specimen, AM-01-2015, has been submitted in Malakand
University herbarium.
Extraction fractionation and isolation of sesquiterpene
lactone
Shade-dried (10 kg) aerial parts of A. macrocephala
were pulverized. This material was then soaked in
commercial grade methanol with occasional stirring.
Filtered the whole suspension after 22 days and re-
peated this process three times. Then combined all the
filtrates and concentrated through rotary evaporator
under reduced pressure at 40 °C. 1 kg of methanolic
greenish-black extract was obtained which was sub-
jected to successive fractionation.
The crude extract was added to 5 l distilled water
followed by the addition of an equal volume of n-hex-
ane and shaken gently in a separating funnel. Col-
lected the n-hexane layer from the separating funnel
and continued this process till there appeared no
color in the n-hexane when added further. Then com-
bined the entire n-hexane portion and subjected to
rotary evaporator at 45 °C, 120 g n-hexane fraction
(12%) was collected. The process was repeated for
chloroform (37.8%), ethyl acetate (12.2%) and n-buta-
nol (15.4%) to obtain their respective fractions. The
remaining aqueous portion left was approximately
210 g (21%).
Chemical characterization of crude extract/fractions and
isolation of sesquiterpene lactone
The crude methanolic extract and fraction were tested
for the presence of terpenoids [34]. The fraction showing
positive result (chloroform fraction) was subjected to
column chromatography for the isolation and purification
of terpenoids by elution with 5% ethyl acetate: n-hexane.
It gave the compound Ism-1 (1.3 g). TLC plate was used
for examining the purity of the compound and visualized
under UV lamp. Further spectral and crystal data lead to
the confirmation of the compound as sesquiterpene
lactone (STL).
DPPH free radical scavenging assay
The antioxidant activity of the isolated STL was car-
ried out through its scavenging ability of DPPH free
radical. Various dilutions of 25, 50, 75, 100, 125 and
150 μM of the isolated compound were mixed with
1 ml solution of DPPH (90 μM) and adjusted the
final volume 4 ml via methanol. After a time period
of 1 h the absorbance of test solutions and the blank
was recorded at room temperature. Ascorbic acid
helped as positive control. Each reading was taken in
triplicate. Percent (%) scavenging of DPPH free rad-
ical was calculated as.
% Scavenging ¼ 100  Ablank Asample= Ablank
 
Where Ablank is absorbance of control, Asample is the
absorbance of the test sample.
IC50 values, which represented the concentration of
test sample that caused 50% neutralization of DPPH radical,
were calculated from the plot of inhibition percentage
against concentrations [35].
ABTS free radical scavenging assay
The antioxidant activity of the isolated compound was
evaluated against ABTS free radical [36]. This is dependent
upon the potential of antioxidants to scavenge ABTS rad-
ical cation causing a reduction in absorbance at 734 nm.
Shortly, K2S2O4 solution (2.45 mM) was mixed with ABTS
(7 mM) solution. Kept this mixture in dark at room
temperature for 14 h which gave a dark color solu-
tion having cation radical of ABTS. The cation rad-
ical solution of ABTS was then diluted with 0.01 M
phosphate buffer of pH 7.4 in order to adjust the absorb-
ance 0.70 at 734 nm. ABTS solution (3 ml) was mixed
with 300 μl of test sample to determine the radical scaven-
ging potential of the test samples. Reduction in absorb-
ance was determined through spectrophotometer after 1
min of the solutions mixing and continued for 6 min.
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Ascorbic acid served as positive control. All the readings
were taken in triplicate. Percentage scavenging was calcu-
lated as:
Antioxidant potential was expressed as percent inhibition
and as IC50 (Test sample concentration required for 50%
reduction of ABTS radicals).
Anticancer activity
Anticancer activity of the isolated STL was carried out
in 96-well flat-bottomed micro plates through standard
MTT (3-[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyl-
tetrazolium bromide) colorimetric assay [37]. For this
purpose, HeLa (Cervical Cancer), MCF-7 (Breast Cancer)
and NIH 3 T3 (Mouse fibroblast) were cultured in Mini-
mum Essential Medium Eagle, supplemented with 5% of
fetal bovine serum (FBS), 100 IU/ml of penicillin and
100 μg/ml of streptomycin in 75 cm2 flasks, kept at 37 °C
in 5% CO2 incubator. Exponentially growing cells were
harvested, counted with haemocytometer and diluted with
a particular medium. Cell culture with the concentration
of 6×104, 5×104 and 5×104 cells/ml for HeLa, MCF-7 and
NIH 3 T3 respectively was prepared and introduced
(100 μL/well) into 96-well plates. After overnight incuba-
tion, medium was removed and 200 μL of fresh medium
was added with different concentrations of compound
(62.5-1000 μg/mL). After 48 h, 200 μL MTT (0.5 mg/ml)
was added to each well and further incubated for 4 h. Sub-
sequently, DMSO (100 μL) was added to each well. The
extent of MTT reduction to formazan within cells was
calculated by measuring the absorbance at 570 nm,
through micro plate reader (Spectra Max plus, Molecular
Devices, CA, USA). The cytotoxicity was recorded as con-
centration causing 50% growth inhibition (IC50) for HeLa.
Percent inhibition was determined as:
% inhibition = 100-[(mean of O.D of test compound –
mean of O.D of negative control)/(mean of O.D of posi-
tive control – mean of O.D of negative control) × 100].
The results (% inhibition) were processed by using
Soft- Max Pro software (Molecular Device, USA).
Acute toxicity
Balb/C mice (18–26gm) were purchased from National
Institute of Health (NIH) Islamabad and housed in sepa-
rated cages at University of Malakand animal house with
free access to standard diet and water and starved for
12–18 h before experimentation. Ethical Committee of
Pharmacy Department, University of Malakand accepted
the protocols (No: S-Ter-24-12/2015) of experimental
and ensured its compliance with provisions of the “Animal
Bye-Laws 2008, Scientific Procedures Issue-I of the
University of Malakand”.
The isolated STL was tested for acute toxicity study as
per standard protocol [38]. Balb C mice were given 25, 50
and 100 mg/kg of the isolated compound in phase first.
While 125, 250 and 500 mg/kg in phase second were
given to the experimental animals. One group, given nor-
mal saline served as control. They were observed for 6 h
continuously for changes in the behavioral or autonomic
responses followed by another examination after 24 h.
Any mortality for the next 14 days was also noted.
Acetic acid induced writhing test
The peripheral antinociceptive response was determined
through acetic acid induced writhing test. Two groups of
mice (n= 6) for each sample were prepared. They were
given 25 and 50 mg/kg of isolated compound 1 h before the
injection of 10 ml/kg of 1% acetic acid intraperitoneally.
Negative control group was given 10 ml/kg of 1% solution
of Tween 80 while positive control group was given 10 mg/
kg of diclofenac sodium intraperitoneally to overnight fast-
ing mice. Writhing and stretching number was noted and
percent protection was determined from the data [39].
Thermal nociception (Tail immersion method)
In order to determine the central antinociceptive re-
sponse of the sample, the animals were given 25 and
50 mg/kg of isolated compound intraperitoneally, 2% ve-
hicle and 10 mg/kg of diclofenac sodium, 30 min prior
to the immersion of the tail (3 cm) into hot water at a
temperature of 55 ± 0.5 °C. To assist the possible in-
volvement of opioid receptor, morphine (agonist) at a
dose of 5 mg and naloxone (antagonist) at a dose of
2 mg were used. The time of reaction taken at 15, 30,
45, 60, 75 and 90 min after administration of sample
were noted with a stopwatch [40].
Formalin induced writhings test
This test was carried out with in Balb C mice using for-
malin. 25 and 50 mg/kg of isolated compound (i.p)
were given to the pre labeled groups. 30 min after the
treatment of test samples, 2.5% formalin (20 μl) was
injected (s.c) in mice hind paw. The time spent in lick-
ing the injected paw in early phase (0–5 min) and late
phase (15–30 min) was recorded. Naloxone, opioid an-
tagonist (2 mg/kg, s.c) and standard drug indomethacin
(10 mg/kg) was also used [41].
% scavenging effect ¼ control absorbance ‐ sample absorbance
control absorbance
 100
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Statistical analysis
All the experiments were carried out in triplicate. The
data was represented as mean ± SEM. Data was sub-
jected to one way ANOVA followed by Dunnetts test for
finding statistical significance. P value less than 0.1 was
considered statistically significant.
Results
Structures of isolated compound
Colorless needle. 1H-NMR (CD3OD, 400 MHz): δ:
4.81 (dd, 1H, J= 1.0 Hz, J= 11.0 Hz, H-6), 2.64 (m, 1H,
H-11), 2.61 (m, 1H, H-2β), 2.47 (m, 1H, H-2α), 2.39
(m, 1H, H-3β), 2.34 (m, 1H, H-3α), 2.17 (m, 1H, H-7),
1.94 (s, 3H, H-15), 1.84 (m, 1H, H-9β), 1.81 (m, 1H,
H-8α), 1.66 (m, 1H, H-8β), 1.51 (m, 1H, H-9α), 1.30 (s,
3H, H-14), 1.19 (d, 3H, J 7.5 Hz, H-13). EI-MS (m/z)
248 [M] + [42].
The title compound (C15H20O3), comprises on one
hexahydroxynaphthol ring (C3/C4/C6-C9/C11-C14),
having a ketonic functionality at C-11 and dimetyl
substitutions at C-8 and C-15 along with five mem-
bered cyclic ester [lactone, C1-C4/O1/O2 (Fig. 1a)].
Ring A adopts a half-chair conformation while ring B
adopts complete chair conformation and ring C possess
enveloped conformations (Fig. 1b). The title compound
has three methyl substitutions, one methyl group is lo-
cated on fused C-8, the second methyl group is located
on C-14 and both has axial orientations. The third me-
thyl group has pseudo-axial orientation on C-2 make
the dihedral angle to the lactone ring (C-C2-C5) is
112.7 (3) °. The torsion angle of the plane (C8-C9-C14-
C13) of ring A is 1.4 (6)°.
In the crystal, asymmetric molecule is directly interlinked
with other four neighboring molecules through intermo-
lecular interactions. Molecules are arranged in the crystal
packing in such a way that making two dimer motifs via C-
H•••O (C6-H6A•••O2= 153.8° and H6A•••O2= 2.709 Ǻ)
and C-H•••C (C5-H5A•••C1 = 164.9° and H5A•••C1 =
2.892 Ǻ) intermolecular hydrogen bonding (Fig. 2c).
Additionally, the O•••H (O2•••H2 = 2.507Ǻ) intermo-
lecular interactions are involved in the formation of
Fig. 1 a ORTEP view of the title molecule with 50% probability, b conformation of rings and orientations of methyl substitutions
Fig. 2 c Formation of dimer via C-H•••O and C-H•••C intermolecular interactions, d molecular packing of compound like zig-zag pattern along a-axis
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zig-zag anti-parallel chain in a two-dimensional net-
work (Fig. 2d).
Hirshfeld surface and fingerprint plots analysis
Hirshfeld surface analysis is a powerful tool in the esti-
mation and understanding the nature of intermolecular
interactions involving in the packing of molecular crystal
by using their fingerprint plots. In the title molecule, the
Hirshfeld surface analysis shows a higher proportion of
H•••H contacts, ranging from 60 to 70% as compared to
O•••H, C•••H contacts (Fig. 3). In this case, the H•••H
(Fig. 4) interactions are represented by the mid area of
the fingerprint plots, which represents an asterisk oxy-
gen interacting with the neighboring α-hydrogen of loca-
tion, forming the zig-zag network of hydrogen bonds
(Fig. 5).
The sharp “wings” seen in the plot belong to C-
H•••O interactions, with the “wings” in the lower area
of the fingerprint plot representing C-H•••O acceptor
(H•••O) interactions. The proportion of O•••H inter-
actions has a larger contribution than its H•••O coun-
terparts. The proportion of O•••H interactions vary
from 10.0 to 13.4%, is mainly due to neighboring ester
group pointing toward the oxygen of the lactone moi-
ety whereas proportion of O•••H interactions ranging
from 12.0 to 15.7%.
Antioxidant activity of the STL towards DPPH and ABTS
free radical scavenging radicals
This method of stable free radical DPPH is normally
used to investigate the anti-oxidant potentials. Here the
Fig. 3 e Hirshfeld surface fingerprint plot, and (f) the dnorm surface of title molecule
Fig. 4 g The proportion of H•••H, (h) O•••H, and (i) C•••H contacts in title molecule
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test was conducted to determine the IC50 value of STL
to scavenge DPPH radicals. The isolated compound
shows a dose dependent activity starting from 26.65 ±
1.04 at the lowest concentration to 68.76 ± 0.82 at the
highest concentration used. The value is reaching to that
of ascorbic acid at the same concentration used as
standard. Other standards, tocopherol and rutin are any-
how having higher values at the same concentration of
150 μg/mL Table 1.
In the ABTS assay, the STL again showed an activity
of 71.76 ± 0.82 at 150 μg/mL, having an excellent activity
reaching to that of ascorbic acid again where as the
other standards tocoperol and rutin are having the read-
ing of 94.33 ± 0.49 and 94.67 ± 0.51 at the same concen-
tration Table 2.
Inhibitory effects of the STL towards the proliferation of
3 T3, HeLa and MCF-7 cells
The sesquiterpenoids have prominent antitumor [25]
and antineoplastic activity [43]. To evaluate such potentials
of the isolated STL, we investigated its effects on 3 T3,
HeLa and MCF-7 cells. The anti-proliferative potentials of
the tested STL are expressed in terms of % cells growth
inhibition and are depicted in Table 3. The isolated com-
pound was found to be very active against HeLa MCF-7
cells. It showed 64.39 ± 2.40 and 81.25 ± 3.07% cell growth
inhibitions against HeLa cell line at 500 and 1000 μg/mL
concentrations respectively. Similarly, it revealed 65.34 ±
2.00 and 73.41 ± 2.11% cell growth inhibition against MCF-
7 cells at 500 and 1000 μg/mL concentrations respectively.
The compound mostly showed no anti-proliferative activity
against 3 T3 cells even at the highest concentration of
1000 μg/mL (43.11 ± 1.34%).
Acute toxicity
According to International regulations concerning hu-
man health oblige that all novel pharmaceutical drugs
are tested for safety before use in human beings. An im-
portant phase in ensuring drug safety is toxicity tests
conduction in proper animal models. The studies of
acute toxicity are among the series of toxicity tests
used. The aim of this test is the identification of a dose
that cause serious adverse effects and evaluation of lowest
dose that cause lethality. The International Conference on
Harmonization in its 3rd meeting (ICH M3) suggests the
acute toxicity studies or appropriate alternatives are essen-
tial before administering new medicine in humans for the
first time [44].
The isolated STL at a highest dose of 500 mg/kg body
weight showed no adverse effect on the behavioral re-
sponses in the tested mice for 14 days observation. No
mortality or weight change observed. The mice were
sacrificed for checking the gross anatomy of liver and
kidney, anyhow, no significant changes were observed
when compared to normal. Therefore, the dose con-
sidered to be safe is 50 mg/kg.
Acetic acid induced writhing
The acetic acid test is implicated for the determination
of peripheral activity. In performing the acetic acid induced
writhing test for the determination of antinociceptive affect,
the sample showed a moderate antinociceptive effect. The
sample mild to moderately inhibited the acetic acid induced
writings with a maximum value of 53.62% (P < 0.01, n = 6)
at 50 mg/kg as shown in Table 4. All the results were com-
pared to the standard (diclofenac sodium, 10 mg/kg) with
83.29% response.
Fig. 5 Percentage contributions to the Hirshfeld surface areas for the various intermolecular contacts (H/H, O/H and C/H) in molecule
Table 1 Percent DPPH radical scavenging activity of STL
25 μg/mL 50 μg/mL 75 μg/mL 100 μg/mL 125 μg/mL 150 μg/mL
Ascorbic acid 67.33 ± 0.41 73 ± 0.61 77.26 ± 0.68 83.09 ± 0.42 87.11 ± 0.87 88.68 ± 0.58
Tocopherol 71.32 ± 0.36 78.16 ± 0.57 85.41 ± 0.61 91.18 ± 0.53 93.24 ± 0.75 94.33 ± 0.49
Rutin 78.03 ± 0.76 84.11 ± 0.43 86.63 ± 0.81 92.25 ± 0.61 94.35 ± 0.66 96.67 ± 0.51
STL 26.65 ± 1.04 31.62 ± 0.67 40.94 ± 0.63 47.63 ± 0.39 54.74 ± 0.86 68.76 ± 0.82
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Formalin test
Formalin test is used for continuous moderate pain. It is
a valid model for pain determination in animal model.
After the administration of the sample to the animals
treated with formalin, it again mildly inhibited the first
phase with 45.16% (**P < 0.01, n = 6) and the second
phase with 51.47% (**P < 0.01, n = 6) at 50 mg/kg.
Animals treated with morphine (5 mg) inhibited signifi-
cantly both the phases with 86.48% (***P < 0.001, n = 6) and
95.82% (***P < 0.001, n = 6) for first phase and second phase
respectively as shown in Table 5. Indomethacin (10 mg/kg)
mildly inhibited the first phase with 27.69% (***P <
0.001, n = 6) and significantly inhibited the second phase
with 73.47% (***P < 0.001, n = 6).
Thermal nociception (tail immersion) test
This test is performed for finding out the central analgesic
response. The samples when tested for its effectiveness in
tail flick model, significantly increased the latency time at
both the doses to 60.00% (**P < 0.01, n = 6) and 57.89%
(**P < 0.01, n = 6) respectively at 25 mg/kg and 62.10% and
61.05% at 60 min at which morphine (opioid analgesic,
centrally acting), showed 85.07% (***P < 0.001, n = 6) ac-
tivity. Naloxone treated animals significantly reduced
the analgesic potentials of morphine and the isolated
compounds (Table 6).
Discussion
STLs are pharmacologically active molecules and have
been reported for various potentials like antitumor,
anti-inflammatory, antibacterial, antifungal, antiviral,
antiprotozoal, antihelminthic, antiulcer, molluscicidal,
hepatoprotective, hepatocurative, and antidepressant
effects [45–65]. The first-line therapy against malaria
caused by Plasmodium falciparum is, as recommended by
the World Health Organization (WHO), a combination
therapy of a STL (artemisinin) and its derivatives with other
antimalarials, such as mefloquine and amodiaquine [66, 67].
Semisynthetic derivatives with improved pharmacokinetic
profiles include the active principle dihydroartemisinin,
artemether, artelinic acid and artesunate [66]. Free radi-
cals production in the living systems leads to a series of
chemical reactions and thus gives rise to serious tissues
injuries and ultimately cancer. STLs have been reported
to be effective in inhibiting free radicals [68]. Data from
the literature show that some species of the genera Arte-
misia possess analgesic activity and these pharmacological
effects have been attributed mainly to flavonoids, alka-
loids, sesquiterpene lactones and essential oils [69]. Cur-
rently, STLs have been the subject of greater scientific
interest due to their ever-increasing evidence concerning
their antitumor properties.
The cytotoxic and apoptotic effects of STLs have
been investigated in vitro against several cancer cell
lines [70–75]. In result of all the chemical and pharmaco-
logical research on STLs, substances such as parthenolide
and its synthetic analog, dimethylaminoparthenolide
(DMAPT), thapsigargin, the artemisinin derivatives arte-
mether and artesunate are presently in cancer clinical trials
[56]. Similarly thapsigargin pro-drug (G-202, thapsigargin
coupled with a masking peptide which is cleaved at the
tumor site, releasing the cytotoxic drug) is in phase I clin-
ical trials for advanced solid tumors. These substances exert
diverse mechanisms of antitumoral action, such as ROS
formation, epigenetic modulation of gene expression,
targeting the sarco/endoplasmic reticulum calcium
ATPase (SERCA) pump, the NF-kB signaling pathway,
the p53 pathway, and inhibiting angiogenesis and me-
tastasis [76, 77]. Most recently, Vernolide from Vernonia
cinerea, has been reported for immunostimulatory effects,
Table 2 Percent ABTS radical scavenging activity of STL
25 μg/mL 50 μg/mL 75 μg/mL 100 μg/mL 125 μg/mL 150 μg/mL
Ascorbic acid 70.23 ± 0.41 77.56 0.61 80.26 ± 0.68 85.09 ± 0.42 87.61 ± 0.87 89.88 ± 0.58
Tocopherol 74.32 ± 0.36 78.16 ± 0.57 86.41 ± 0.61 91.18 ± 0.53 93.84 ± 0.75 94.33 ± 0.49
Rutin 79.03 ± 0.76 85.11 ± 0.43 87.63 ± 0.81 89.25 ± 0.61 92.35 ± 0.66 94.67 ± 0.51
STL 30.65 ± 1.04 33.62 ± 0.67 42.94 ± 0.63 45.63 ± 0.39 61.74 ± 0.86 71.76 ± 0.82
Table 3 In-Vitro anti-proliferative activity (% cell growth inhibition)
of STL against 3 T3, HeLa and MCF-7 cell lines
Sample Concentration
(μg/mL)
3 T3 HeLa MCF-7
STL 1000 43.11 ± 1.34 81.25 ± 3.07 73.41 ± 2.11
500 28.25 ± 2.00 64.39 ± 2.40 65.34 ± 2.00
250 21.91 ± 1.05 53.56 ± 2.00 49.62 ± 2.32
125 15.00 ± 0.52 37.58 ± 1.78 35.50 ± 1.00
62.5 09.25 ± 1.56 24.67 ± 1.65 27.50 ± 0.85
Table 4 Acetic acid induced writhing response of pure
compounds
Treatment/Dose Number of writhing % inhibition
Control (2% Tween 80) 69.75 ± 1.45 —
Diclofenac sodium (10 mg) 11.65 ± 2.02 83.29
Ism-1 25 mg
50 mgs
54.66 ± 1.20* 21.63
32.35 ± 1.35** 53.62
All the values were expressed as mean ± SEM (n = 6). *P < 0.1, **P < 0.01 when
compared to control group (one way ANOVA followed by Dunnetts: compare
all vs control test)
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inducing enhanced cellular and humoral responses against
tumors [78]. Our STL showed good inhibition of gowning
cancer cell (HeLa and MCF-7 in case of this study). Al-
though it did not show good results against 3 T3 cell line,
may be due the cell line nature that is not enough sensi-
tive like the other two. The possible mechanism for the
anti-proliferative activity of the tested STL may be its
ability to simultaneously target two molecular pathways
(NF-kB and p53) as reported for other STLs elsewhere
in literature [79]. Thus, the results of the present study
reveal the possible potentials of the isolated STL for its
anti-proliferative activity.
The scavenging of free radicals has been important as
it helps in preventing the tissues and other vital organs
injuries. The isolated STL was screened for free radicals
scavenging potentials using DPPH and ABTS free radicals.
It caused the scavenging of both the free radicals in a con-
centration dependent manner. It was found quite effective
against the tested free radicals. The isolated STL will re-
quire to be extensively studied for its antioxidant activity
possible mechanism but mostly STLs have been reported
to exert their antioxidant activity through the activation of
antioxidant response element (ARE) gene [68]. The results
of the present study suggest the possible uses of the
isolated STL in free radicals caused tissues injuries.
antinociceptiveantinociceptive. Three different models,
visceral nociception, inflammatory nociception and thermal
and neurogenic nociception, were used to investigate the
antinociceptive effects of the STL. Abdominal constriction
assay induced with acetic acid [80] is considered to be
sensitive using minimum quantity of noxious stimulus
and the results can detect even a weak analgesic. This
method is used for investigation of peripheral anal-
gesic response. The acetic acid increases prostaglandin
level (especially PGE2) in the mice peritoneal fluid
[81]. Prostaglandins activate abdominal constriction
via sensitizing and activating peripheral chemo-sensitive
nociceptors [82] which are mainly involved in inflamma-
tory pain [83].
Nociception induced with formalin is used to meas-
ure the potentials of a substance to relieve continuous
moderate pain generated as a result of tissue injury [84].
Formalin induced acute and chronic phases of nociception
are regarded to indicate neurogenic and inflammatory pain
behaviors respectively. The acute phase is due to direct
chemical stimulation of nociceptive afferent fibers (mostly
Table 5 Formalin-induced paw-licking response of pure compounds
Treatment/Dose Licking time (Sec) Inhibition (%)
1st Phase 2nd Phase 1st Phase 2nd Phase
Control (2% Tween 80) 51.85 ± 1.83 73.05 ± 1.75 —— ——
Morphine 5 mg 7.01 ± 1.153*** 3.05 ± 1.290*** 86.48 95.82
Indomethacin 10 mg 37.35 ± 1.37** 19.38 ± 1.440*** 27.69 73.47
Ism-1 25 mg
50 mg
32.45 ± 1.231* 41.12 ± 1.204* 37.41 43.70
28.43 ± 1.356** 35.45 ± 1.198** 45.16 51.47
All the values were expressed as mean ± SEM (n = 6). *P < 0.1, **P < 0.01 and ***P < 0.001 when compared to control group (one way ANOVA followed by Dunnetts:
compare all vs control test)
Table 6 Tail flick response of isolated compounds
Treatment/
Dose
Time in Sec (Tail Flick)/Response (%)
15 min 30 min 45 min 60 min 75 min 90 min
Control
(2% Tween 80)







































N + 1 25 mg
50 mg
0.93 ± 0.045 0.94 ± 0.043 1.10 ± 0.052 0.99 ± 0.052 0.90 ± 0.058 0.93 ± 0.096
0.89 ± 0.039 0.95 ± 0.068 1.50 ± 0.064 0.99 ± 0.047 0.89 ± 0.080 0.95 ± 0.089
M + N 0.80 ± 0.046 0.87 ± 0.037 0.94 ± 0.045 0.91 ± 0.033 0.91 ± 0.034 0.91 ± 0.045
All the values were expressed as mean ± SEM (n = 6). *P < 0.05, **P < 0.01 and ***P < 0.001 when compared to control group (one way ANOVA followed by
Dunnetts: compared all vs control test)
Key: M Morphine 5 mg, N Naloxone 2 mg
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C fibers) which can be suppressed by opiate like morphine
[85]. The 2nd phase is due to release of inflammatory medi-
ators such as histamine, prostaglandins, bradykinin, sero-
tonin in the peripheral tissues [85], and from functional
changes in the spinal dorsal horn [86]. The tail immersion
test is used to determine the spinal pathways in regulation
of pain response [87]. This method utilizes elevated thermal
nociception and test samples showing good antinociceptive
results in this way are regarded potent analgesics [86].
In tail immersion test, a little increase in reaction time
after treatment with the sample indicates that the isolated
compound is having moderate efficacy in a model of ther-
mal nociception. antinociceptiveThe nociceptive patterns
after formalin injection were particularly recorded in two
phases. In first phase, paw licking/biting response starts
immediately after injection and this may be considered due
to direct stimulation of nociceptors [88]. Second phase ap-
pears little later and is regarded to be due to combination
of inflammatory reactions in the peripheral tissue and
changes in central processing’s [89]. A moderate increase in
the antinociceptive effect was observed against both neuro-
genic (early phase) and inflammatory (late phase) pain
behavior caused by formalin. The magnitude of inhibition
in both the phases was moderate for the isolated com-
pound. It may be suggested from the results that the
isolated compound have no prominent antinociceptive
potentials.
Conclusion
Sesquiterpenes lactones (STLs) have been isolated from
numerous genera of the family Asteraceae (compositae)
and can also be found in other angiosperm families.
They are described as the active constituents of a variety
of medicinal plants used in traditional medicine for the
treatment of various diseases. They are known to possess
wide variety of biological and pharmacological activities
such as antimicrobial, cytotoxic, anti-inflammatory, anti-
viral, antibacterial, antifungal activities, effects on the
central nervous and cardiovascular systems as well as
allergenic potency. Their wide structural diversity and
potential biological activities have made further interest
in the field of Pharmacy and Pharmacology. The present
study was designed to isolate the STLs from A. macroce-
phala and to investigate their possible antioxidant, anti-
cancer and antinociceptive potentials. The study reveals
the significant potentials of STL and may be used as an
alternative for the management of cancer. Anyhow, the
isolated compound is having no prominent antinocicep-
tive potentials.
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